These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 22631038

  • 1. Contemporary approaches to treatment of beta-thalassemia intermedia.
    Taher AT, Musallam KM, Karimi M, Cappellini MD.
    Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
    [Abstract] [Full Text] [Related]

  • 2. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
    Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A.
    Pediatr Hematol Oncol; 2014 Oct; 31(7):583-96. PubMed ID: 25247665
    [Abstract] [Full Text] [Related]

  • 3. Optimal management of β thalassaemia intermedia.
    Taher AT, Musallam KM, Cappellini MD, Weatherall DJ.
    Br J Haematol; 2011 Mar; 152(5):512-23. PubMed ID: 21250971
    [Abstract] [Full Text] [Related]

  • 4. [Current management of thalassemia intermedia].
    Thuret I.
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [Abstract] [Full Text] [Related]

  • 5. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.
    Musallam KM, Cappellini MD, Wood JC, Taher AT.
    Blood Rev; 2012 Apr; 26 Suppl 1():S16-9. PubMed ID: 22631036
    [Abstract] [Full Text] [Related]

  • 6. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM, Cappellini MD, Taher AT.
    Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
    [Abstract] [Full Text] [Related]

  • 7. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.
    Eur J Haematol; 2010 Jan 01; 84(1):72-8. PubMed ID: 19732137
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cross-talk between available guidelines for the management of patients with beta-thalassemia major.
    Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB.
    Acta Haematol; 2013 Jan 01; 130(2):64-73. PubMed ID: 23485589
    [Abstract] [Full Text] [Related]

  • 12. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D.
    Haematologica; 2006 May 01; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [Abstract] [Full Text] [Related]

  • 13. β-thalassemia intermedia: a clinical perspective.
    Musallam KM, Taher AT, Rachmilewitz EA.
    Cold Spring Harb Perspect Med; 2012 Jul 01; 2(7):a013482. PubMed ID: 22762026
    [Abstract] [Full Text] [Related]

  • 14. Thalassemia Intermedia: Chelator or Not?
    Lee YC, Yen CT, Lee YL, Chen RJ.
    Int J Mol Sci; 2022 Sep 05; 23(17):. PubMed ID: 36077584
    [Abstract] [Full Text] [Related]

  • 15. Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications.
    Farmaki K, Tzoumari I, Pappa C.
    Blood Cells Mol Dis; 2011 Jun 15; 47(1):33-40. PubMed ID: 21531154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Common queries in thalassemia care.
    Panigrahi I, Marwaha RK.
    Indian Pediatr; 2006 Jun 15; 43(6):513-8. PubMed ID: 16820660
    [Abstract] [Full Text] [Related]

  • 18. Revisiting beta thalassemia intermedia: past, present, and future prospects.
    Ben Salah N, Bou-Fakhredin R, Mellouli F, Taher AT.
    Hematology; 2017 Dec 15; 22(10):607-616. PubMed ID: 28589785
    [Abstract] [Full Text] [Related]

  • 19. Thalassemia intermedia today: should patients regularly receive transfusions?
    Aessopos A, Kati M, Meletis J.
    Transfusion; 2007 May 15; 47(5):792-800. PubMed ID: 17465943
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A, Farmakis D, Deftereos S, Tsironi M, Polonifi A, Moyssakis I, Diamanti-Kandaraki E, Papalambros E.
    Ann Hematol; 2005 Jun 15; 84(6):353-7. PubMed ID: 15711802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.